In 2024, UAB "Nobel Biocare" had revenue of 2.1 million EUR.
Warning
Possible tax debts
| year | 2024Latest | 2023 | 2022 |
|---|---|---|---|
Revenue | 2,1m € | 0 € | 0 € |
Profit | - | - -100.0% | 16k € +396.8% |
Assets | - | - | - |
Liabilities | - | - | - |
Equity | - | - | - |
Employees | - | - | - |
Overall rating | B65/100 |
Financial health | 50/100 |
Credit history | 70/100 |
Legal history | 85/100 |
Business activity | 60/100 |
| Overall risk | Medium |
Possible tax debts | |
Possible tax debts | |
No financial data available | |
Regular report filing | |
| Description | Registered |
|---|---|
| Board (2 members: 1M/1F) |
| Description | Registered |
|---|---|
| CEO (Male) |
UAB "Nobel Biocare" is located at Vilnius, Antano Tumėno g. 4, LT-01109, LT-LT-01109.
The shareholders of UAB "Nobel Biocare" include 1 Lithuanian legal entities. View ownership details →
Yes, UAB "Nobel Biocare" is registered as an active VAT payer with VAT number LT100002105213.
UAB "Nobel Biocare" was founded on January 6, 2006. The company has been operating for 20 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 20 years | 60 - 64 | 66% | |
Net revenue | 2 098 995,00 € | 60 - 64 | 66% | |
Registered capital | 81 088,00 € | - | 90% |
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Annual financial report for 2021.
Annual financial report for 2020.
Annual financial report for 2019.
Registered in the Lithuanian register of legal entities.